Device Trial Radar · NCT04969380
SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
Last checked: Nov 20, 2026Latest source record: Nov 18, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
20
Actual
Start
Feb 27, 2020
Primary completion
Feb 27, 2023
Study completion Feb 27, 2023
Sponsor
- Lead sponsor
- Sofwave Medical LTDNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jul 20, 2021
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 35 years, up to 80 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.
Conditions
- Skin Laxity
Interventions
SofwaveDevice
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in lift of lax tissueTime frame: 3 and 6 months post last treatment
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University of California
Irvine, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.